1. Yin, Chunzhao, Zhang, Cunzhen, Wang, Yongqiang, Tao, Yongzhen, Yin, Huiyong. 2023. ALDOB/KAT2A interactions epigenetically modulate TGF-β expression and T cell functions in hepatocellular carcinogenesis. In Hepatology (Baltimore, Md.), 81, 77-93. doi:10.1097/HEP.0000000000000704. https://pubmed.ncbi.nlm.nih.gov/38051951/
2. Niu, Lili, Geyer, Philipp E, Wewer Albrechtsen, Nicolai J, Hofmann, Susanna M, Mann, Matthias. 2019. Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease. In Molecular systems biology, 15, e8793. doi:10.15252/msb.20188793. https://pubmed.ncbi.nlm.nih.gov/30824564/
3. Beyzaei, Zahra, Ezgu, Fatih, Imanieh, Mohammad Hadi, Honar, Naser, Geramizadeh, Bita. 2023. Identification of a novel mutation in the ALDOB gene in hereditary fructose intolerance. In Journal of pediatric endocrinology & metabolism : JPEM, 36, 331-334. doi:10.1515/jpem-2022-0566. https://pubmed.ncbi.nlm.nih.gov/36659819/
4. Gu, Li, Zhu, Yahui, Watari, Kosuke, Simon, M Celeste, Karin, Michael. 2023. Fructose-1,6-bisphosphatase is a nonenzymatic safety valve that curtails AKT activation to prevent insulin hyperresponsiveness. In Cell metabolism, 35, 1009-1021.e9. doi:10.1016/j.cmet.2023.03.021. https://pubmed.ncbi.nlm.nih.gov/37084733/
5. Liu, Guijun, Wang, Ningning, Zhang, Cunzhen, Tao, Yongzhen, Yin, Huiyong. 2021. Fructose-1,6-Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis. In Hepatology (Baltimore, Md.), 74, 3037-3055. doi:10.1002/hep.32064. https://pubmed.ncbi.nlm.nih.gov/34292642/
6. Xu, Jing-Xuan, Qin, Shui-Lin, Wei, Hao-Wen, Peng, Yu-Chong, Qi, Lu-Nan. . Down-regulation of ALDOB during metabolic reprogramming mediates malignant behavior in hepatocellular carcinoma and insensitivity to postoperative adjuvant transarterial chemoembolization. In Clinical science (London, England : 1979), 137, 303-316. doi:10.1042/CS20220661. https://pubmed.ncbi.nlm.nih.gov/36749124/
7. Li, Xiao-Yang, Xu, You-Yao, Wu, Sen-Yan, Zhou, Yan, Cheng, Guo-Bin. 2024. Identification of ALDOB as a novel prognostic biomarker in kidney clear cell renal cell carcinoma. In Heliyon, 10, e29368. doi:10.1016/j.heliyon.2024.e29368. https://pubmed.ncbi.nlm.nih.gov/38655323/
8. Shao, Yuan, Wu, Bo, Yang, Zhen, Wang, Yong, Niu, Yuanjie. . ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma. In Translational andrology and urology, 12, 549-571. doi:10.21037/tau-22-743. https://pubmed.ncbi.nlm.nih.gov/37181232/
智鼠故事 
